Patient Guide: Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06797362
Status: AVAILABLE
Condition: Non Small Cell Lung Cancer, ROS1-positive Non-Small Cell Lung Cancer (NSCLC)
Phase: Not Specified

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Boston, Massachusetts
  • • Philadelphia, Pennsylvania
  • • Camperdown, New South Wales
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors - Join Clinical Trial NCTNCT06797362

How to Join This Clinical Trial - NCTNCT06797362

Learn how to participate in this Not Specified trial studying an investigational therapy for Non Small Cell Lung Cancer, ROS1-positive Non-Small Cell Lung Cancer (NSCLC). Current status: AVAILABLE.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non Small Cell Lung Cancer, ROS1-positive Non-Small Cell Lung Cancer (NSCLC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non Small Cell Lung Cancer, ROS1-positive Non-Small Cell Lung Cancer (NSCLC)
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
AVAILABLE
Study Identifier
NCTNCT06797362 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: AVAILABLE

Clinical Research Site

Philadelphia, Pennsylvania 19111 - United States

Status: AVAILABLE

Clinical Research Site

Camperdown, New South Wales 2050 - Australia

Status: AVAILABLE

Clinical Research Site

Melbourne, Victoria 3000 - Australia

Status: AVAILABLE

Clinical Research Site

Toronto, Ontario M5G 2M9 - Canada

Status: AVAILABLE

Clinical Research Site

Lyon, Auvergne-Rhône-Alpes 69008 - France

Status: AVAILABLE

Clinical Research Site

Villejuif, le-de-France 94800 - France

Status: AVAILABLE

Clinical Research Site

Toulouse, Occitanie 31059 - France

Status: AVAILABLE

Clinical Research Site

Nantes, Pays de la Loire Region 44800 - France

Status: AVAILABLE

Clinical Research Site

Villejuif, Île-de-France Region 94800 - France

Status: AVAILABLE

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Non Small Cell Lung Cancer, ROS1-positive Non-Small Cell Lung Cancer (NSCLC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships